Biolase Aktie - Fundamentalanalyse - Dividendenrendite KGV

Biolase (ISIN: US0909111082, WKN: 894190) Kursdatum: 18.06.2018 Kurs: 1,230 USD
Beschreibung Daten
Symbol BIOL
Marktkapitalisierung 18.144.714,00 USD
Land Vereinigte Staaten von Amerika
Indizes NASDAQ Comp.
Sektor Pharma
Rohdaten nach US GAAP in Millionen USD
Aktiensplits 2018-05-11 - 1.0000/5.0000 | 2014-03-12 - 201.0000/200.0000 | 2013-12-12 - 1004.0000/1000.0000 | 2013-08-28 - 1004.0000/1000.0000 | 2013-06-12 - 1004.0000/1000.0000 | 2013-03-13 - 201.0000/200.0000 | 2012-12-12 - 201.0000/200.0000 | 2012-09-12 - 1005.0000/1000.0000 | 2012-06-06 - 201.0000/200.0000 | 2012-03-13 - 201.0000/200.0000 | 2011-11-22 - 101.0000/100.0000 | 2011-08-25 - 101.0000/100.0000 | 2011-06-08 - 101.0000/100.0000 | 2011-03-11 - 101.0000/100.0000 | 1994-02-15 - 1.0000/4.0000 |
Internet www.biolase.com
Letztes Bilanz Update 16.03.2018

Fundamentaldaten

Fundamental Verhältnisse errechnet am: 18.06.2018
KFCV KCV DIV Rendite GKR EKQ KGV KUV KBV
-0,95 -0,99 0,00% -48,05 68,07 -0,88 0,39 0,62

Firmenbeschreibung

BIOLASE, Inc., a medical device company, develops, manufactures, markets, and sells laser systems in dentistry and medicine for patients and health care professionals in the United States and internationally. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; and diode laser systems, which are used to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of dental procedures, such as cosmetic, restorative, and complex surgical applications. The company also markets, sells, and distributes dental imaging equipment, including three-dimensional (3D) CAD/CAM intra-oral scanners and digital dentistry software. Its dental imaging products comprise 3Shape Trios intraoral scanners, digital impression systems, and software for taking 3D scans, which are used to design crowns, study models, surgical guides for implant placement, and event orthodontic and athletic appliances. In addition, the company manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces. It sells its products primarily to dentists in general practice through its field sales force and distributor network. BIOLASE, Inc. was founded in 1984 and is headquartered in Irvine, California.

Die Finanzoo GmbH übernimmt keine Haftung für die Richtigkeit der Angaben! Alle Angaben sind ohne Gewähr. Quellen: www.bundesanzeiger.de, www.sec.gov, www.biolase.com